NovaBay Pharmaceuticals, Inc. (NBY)
6.20
+1.34
(+27.57%)
USD |
NYAM |
Dec 30, 16:00
5.84
-0.36
(-5.81%)
After-Hours: 07:07
NovaBay Pharmaceuticals EPS Diluted (Quarterly): -0.22 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cassava Sciences, Inc. | -0.2237 |
| cbdMD, Inc. | -0.0762 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.333M |
| Revenue (Quarterly) | 0.521M |
| Total Expenses (Quarterly) | 1.854M |
| Enterprise Value | 784.24M |
| Gross Profit Margin (Quarterly) | 8.06% |
| Profit Margin (Quarterly) | -255.9% |
| Earnings Yield | 9.60% |
| Normalized Earnings Yield | 10.84 |